Blood Clots during Perimenopause

FDA removes warning labels on Menopause Hormone Therapy

US FDA to drop black box warnings from menopause hormone therapies

The U.S. Food and Drug Administration said on Monday it would remove the strictest "black box" warnings from hormone therapies used to treat menopause symptoms, a move that may boost access to treatme...

· 2d

FDA reverses decades of guidance on hormone therapy for menopause

· 2d

The FDA removes a long-standing warning from hormone-based menopause drugs

· 1d

The FDA Removes a Long-Standing Warning From Hormone-Based Menopause Drugs

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Adm...

· 1d

Watch: FDA Commissioner on lifting warnings on hormone therapy for menopause

· 1d

FDA makes major move on women’s health: What is changing?

5don MSN

Perimenopause Raises Your Risk of Stroke—But These Habits Can Help Undo Its Effects

The estrogen deficit of perimenopause can also slow down your metabolism—an outcome of aging as well—and make you less sensitive to the hormone insulin, which can lead to high blood sugar levels and weight gain, particularly in your belly. All of these changes, Dr. Javaid adds, can further pile onto the likelihood of stroke.

7hon MSN

FDA action expected to benefit millions going through menopause

In a pivotal move, the Food and Drug Administration announced action set to benefit millions of women going through menopause.The FDA says they’re taking steps to get rid of black box warnings on many hormone therapy treatments in an effort to improve the health of women.

The Journal Record

FDA to drop black box warnings from menopause hormone therapies

FDA removes strict black box warnings on menopause hormone therapies, expanding access and approving new treatments for symptom relief.